Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Hilton

Showing results (61-70 of 134) with videos related to

Pageof 14
Sort By:
Investigational New Drugs|April 18, 2019
A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumorsJeffrey P Sharman, Jennifer J Wheler, Lawrence Einhorn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2009
Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humansChristopher J Endres, Martin G Pomper, Michelle James, et al.
Nuclear Medicine and Biology|June 29, 2002
Radiosynthesis and mouse brain distribution studies of [11C] CP-126,998: a PET ligand for in vivo study of acetylcholinesteraseJohn L Musachio, John E Flesher, Ursula A Scheffel, et al.
Molecular Imaging|August 19, 2003
11C-MCG: synthesis, uptake selectivity, and primate PET of a probe for glutamate carboxypeptidase II (NAALADase)Martin G Pomper, John L Musachio, Jiazhong Zhang, et al.
Clinical Breast Cancer|September 26, 2019
Selecting Patients for Oncotype DX Testing Using Standard Clinicopathologic InformationSusan J Robertson, Greg R Pond, John Hilton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 8, 2002
Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditionsZsolt Szabo, Una D McCann, Alan A Wilson, et al.
Journal of Epidemiology and Community Health|April 19, 2015
Alignment of systematic reviews published in the Cochrane Database of Systematic Reviews and the Database of Abstracts and Reviews of Effectiveness with global burden-of-disease data: a bibliographic analysisSze Lin Yoong, Alix Hall, Christopher M Williams, et al.
Breast Cancer Research and Treatment|May 13, 2019
De-escalation of bone-modifying agents in patients with bone metastases from breast cancer: a systematic review and meta-analysisArif Ali Awan, Brian Hutton, John Hilton, et al.
Journal of Medicinal Chemistry|July 22, 2008
Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA)Sangeeta R Banerjee, Catherine A Foss, Mark Castanares, et al.
Access Microbiology|January 16, 2023
Case report: a fatal case of <i>Aspergillus felis</i> infection in an immunocompetent hostJill Parkes-Smith, Michelle J Bauer, Haakon Bergh, et al.
Pageof 14

Showing results (61-70 of 134) with videos related to

Sort By:
Pageof 14
Investigational New Drugs|April 18, 2019
A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumorsJeffrey P Sharman, Jennifer J Wheler, Lawrence Einhorn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2009
Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humansChristopher J Endres, Martin G Pomper, Michelle James, et al.
Nuclear Medicine and Biology|June 29, 2002
Radiosynthesis and mouse brain distribution studies of [11C] CP-126,998: a PET ligand for in vivo study of acetylcholinesteraseJohn L Musachio, John E Flesher, Ursula A Scheffel, et al.
Molecular Imaging|August 19, 2003
11C-MCG: synthesis, uptake selectivity, and primate PET of a probe for glutamate carboxypeptidase II (NAALADase)Martin G Pomper, John L Musachio, Jiazhong Zhang, et al.
Clinical Breast Cancer|September 26, 2019
Selecting Patients for Oncotype DX Testing Using Standard Clinicopathologic InformationSusan J Robertson, Greg R Pond, John Hilton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 8, 2002
Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditionsZsolt Szabo, Una D McCann, Alan A Wilson, et al.
Journal of Epidemiology and Community Health|April 19, 2015
Alignment of systematic reviews published in the Cochrane Database of Systematic Reviews and the Database of Abstracts and Reviews of Effectiveness with global burden-of-disease data: a bibliographic analysisSze Lin Yoong, Alix Hall, Christopher M Williams, et al.
Breast Cancer Research and Treatment|May 13, 2019
De-escalation of bone-modifying agents in patients with bone metastases from breast cancer: a systematic review and meta-analysisArif Ali Awan, Brian Hutton, John Hilton, et al.
Journal of Medicinal Chemistry|July 22, 2008
Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA)Sangeeta R Banerjee, Catherine A Foss, Mark Castanares, et al.
Access Microbiology|January 16, 2023
Case report: a fatal case of <i>Aspergillus felis</i> infection in an immunocompetent hostJill Parkes-Smith, Michelle J Bauer, Haakon Bergh, et al.
Pageof 14